[Restless leg syndrome: diagnosis and treatment].
Although it may have significant adverse impact on quality of life of patients who suffer from it, restless legs syndrome remains a largely overlooked disorder. In addition to sensorimotor discomfort, it may also be a significant cause of excessive daytime sleepiness or fatigue. The dopamine agonists ropinirole and pramipexole are currently considered to be the agents of choice for the treatment of RLS. A number of non-pharmacological maneuvers may also be beneficial and complement pharmacological treatments.
D006801:Humans; D012148:Restless Legs Syndrome / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology